Expanding Minimally Invasive Procedures Will Open US And European Markets

Shared on01 May 25
Fair value Decreased 1.92%

Shared on24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 0.89%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 4.27%

AnalystConsensusTarget has increased shares outstanding growth rate from 0.0% to 0.0%.